CHICAGO (Reuters) - U.S. researchers have developed tiny nanoparticle robots that can travel through a patient’s blood and into tumors where they deliver a therapy that turns off an important cancer gene.
CHICAGO (Reuters) - U.S. researchers have developed tiny nanoparticle robots that can travel through a patient’s blood and into tumors where they deliver a therapy that turns off an important cancer gene.
